BRITTANY STUDWOOD: Open Payments
NPI 1396168043 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 17 payments from 6 companies in 2025. Trend: 2023 $56 · 2024 $155 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $289 |
| Mallinckrodt Hospital Products Inc. | 4 | $261 |
| Melinta Therapeutics, LLC | 3 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| ABBVIE INC. | 1 | $32 |
Products named: TERLIVAZ, Rezzayo, Biktarvy, JARDIANCE, Fabhalta, AVYCAZ.
Industry payments across NY — which companies pay providers there.
